Page last updated: 2024-12-06
dioxacarb
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dioxacarb: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 23421 |
| CHEMBL ID | 3188645 |
| CHEBI ID | 82093 |
| SCHEMBL ID | 119641 |
| MeSH ID | M0062163 |
Synonyms (62)
| Synonym |
|---|
| carbamic acid, methyl-, o-(1,3-dioxolan-2-yl)phenyl ester |
| phenol, 2-(1,3-dioxolan-2-yl)-, methylcarbamate |
| elocron 8353 |
| 2-(1,3-dioxolan-2-yl)phenyl-n-methylcarbamat [german] |
| dioxacarb [ansi:bsi:iso] |
| mcdp |
| c 8353 |
| ai3-27389 |
| ent 27,389 |
| caswell no. 393a |
| einecs 230-253-4 |
| dioxacarb |
| elocron |
| epa pesticide chemical code 392100 |
| du pont insecticide 1519 |
| ciba c 8353 |
| c-8353 , |
| dioxokarb [polish] |
| carbamic acid, methyl-, o-1,3-dioxolan-2-ylphenyl ester |
| ciba 8353 |
| famid |
| rovlinka |
| nsc 190981 |
| elocron 50wp |
| brn 1348191 |
| dioxacarbe |
| 2-(1,3-dioxolan-2-yl)phenol methylcarbamate |
| o-(1,3-dioxolan-2-yl)phenyl methylcarbamate |
| dioxacarbe [iso-french] |
| du pont 1519 |
| dioxocarb |
| 2-(1,3-dioxolan-2-yl)phenyl methylcarbamate |
| [2-(1,3-dioxolan-2-yl)phenyl] n-methylcarbamate |
| C18953 |
| 6988-21-2 |
| dtxcid0021886 |
| NCGC00255496-01 |
| cas-6988-21-2 |
| tox21_302420 |
| dtxsid2041886 , |
| 2-(1,3-dioxolan-2-yl)phenyl-n-methylcarbamat |
| 698bek3133 , |
| 5-19-02-00547 (beilstein handbook reference) |
| unii-698bek3133 |
| dioxokarb |
| AKOS015902513 |
| dioxacarb [iso] |
| phenol, 2-(1,3-dioxolan-2-yl)-, 1-(n-methylcarbamate) |
| 2-(1,3-dioxolane-2-yl)-phenyl n-methylcarbamate |
| 2-(1,3-dioxolan-2-yl)phenyl n-methylcarbamate |
| du pont-1519 |
| elocron-8353 |
| SCHEMBL119641 |
| CHEBI:82093 , |
| 2-(1,3-dioxolan-2-yl)phenyl methylcarbamate # |
| elecron 50 |
| 2-(1,3-dioxolane-2-yl)phenyl n-methylcarbamate |
| CHEMBL3188645 |
| pesticide3_dioxacarb_c11h13no4_phenol, 2-(1,3-dioxolan-2-yl)-, methylcarbamate |
| FT-0667620 |
| Q22807435 |
| o-(1,3-dioxalan-2-yl)phenyl methylcarbamate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
| Class | Description |
|---|---|
| benzenes | Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Protein Targets (4)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 0.5421 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
| AR protein | Homo sapiens (human) | Potency | 46.6943 | 0.0002 | 21.2231 | 8,912.5098 | AID743035; AID743036 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 59.1188 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 21.7681 | 0.0420 | 27.3789 | 61.6448 | AID743210 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 23.88
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.88) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||